Method of culturing cells in suspension using lectins

Details Method of culturing cells in suspension using lectins Method of culturing cells in suspension using lectins

1999-06-28

2001-06-26

Lankford, Jr., Leon B. (Department: 1651)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Method of culturing cells in suspension

C435S346000, C435S404000, C435S325000

Reexamination Certificate

active

06251670

ABSTRACT:

BACKGROUND OF THE INVENTION
The present invention relates to a method of perfusion culture using a naturally-occurring agglutinin.
It has been strongly desired to develop a technique for producing useful bioactive substances such as hormones, cytokines, and monoclonal antibodies in a large amount by culturing a large amount of cells. In consideration of an industrial scale production, suspension culture, in which cells are proliferated while floating in a culture medium without attaching to a culture immobilization carrier, is considered as the most useful method since the production is easily scaled up.
However, in the cell culture, since growth inhibitors are excreted from the cells, cell proliferation will stop at a relatively low cell density unless the culture medium containing the growth inhibitor is removed. Hence, to culture cells in a large amount and with a high density, it is necessary to perform perfusion culture while old culture medium containing the growth inhibitors is appropriately discharged from a vessel and replaced with fresh culture medium.
To perform the perfusion culture, it is very important to precipitate living cells quickly in the culture medium in order to separate the living cells and the old culture medium, thereby discharging the old culture medium from a culture vessel.
Conventional methods to separate the culture medium and the living cells include (1) a method using a filter, (2) a method using gravity, (3) a method using a centrifuge, and (4) a method immobilizing cells to a carrier.
However, the method (1) has a problem in that filter clogging takes place. The method (2) has a problem in that separation efficiency is low since the specific gravity of animal cells is about 1.1. The method (3) has problems in that the apparatus has a complicated structure, and that the centrifugal force will have an adverse effect on the cells. The method (4) has drawbacks in that a troublesome operation is required for immobilization, and that it is difficult to scale up the production. As described, none of them is a satisfactory method for culturing a large amount of cells.
Furthermore, Japanese Patent Application KOKAI Publication No. 1-165374 discloses a method for improving separation efficiency of the cells from a culture medium by agglutinating the cells by addition of a mixture of polyacrylic acid and chitosan as an agglutinant, to the culture medium. All drawbacks associated with the aforementioned methods can be overcome by this method.
However, this method has the following disadvantages.
(i) Polyacrylic acid and chitosan, which are non-biological substances, may possibly cause cytotoxicity.
(ii) Relatively large amount of polyacrylic acid/chitosan (50-200 &mgr;g/mL) is needed to effectively agglutinate animal cells.
(iii) Chitosan produced from chitin by its heat treatment under strong alkali condition is not uniform from lot to lot. This non-uniformity is inappropriate for the process of producing medicine with respect to safety.
(iv) Agglutinate formed with polyacrylic acid/chitosan are too large (0.1 to 2.0 mm in diameter) for its core to be supplied with enough oxygen and nutrients.
BRIEF SUMMARY OF THE INVENTION
An object of the present invention is to provide a method of attaining perfusion culture efficiently and simply by agglutinating cells with lectin, which is a naturally occurring agglutinative substance, thereby separating the cells and culture medium.
To attain the aforementioned object, the present invention provides a method of culturing cells comprising the steps of:
(1) suspending cells in a culture medium before or after lectin is added to the culture medium, and culturing the cells;
(2) separating the cells agglutinated by an action of lectin in the culture medium from the culture medium and removing all or a portion of the culture medium;
(3) replenishing the cells with fresh culture medium, adding lectin to the culture medium at any timepoint, and culturing the cells; and
(4) repeating operations set forth in the steps (2) and (3) for times arbitrarily set.
Additional objects and advantages of the invention will be set forth in the description which follows, and in part will be obvious from the description, or may be learned by practice of the invention. The objects and advantages of the invention may be realized and obtained by means of the instrumentalities and combinations particularly pointed out hereinafter.


REFERENCES:
patent: 4594327 (1986-06-01), Zuk
patent: 4695553 (1987-09-01), Wardlaw et al.
patent: 5693760 (1997-12-01), Seilhammer et al.
patent: 1-165374 (1989-06-01), None
R. Baluna et al, (Abstract) “Fibronectin Inhibits the Cytotoxic Effect of Ricin A Chain on Endothelial Cells”, Journal: Int. J. Immunopharmacol., vol. 18, Issue 6-7, pp. 355-361 (1996).
R. Baluna et al, (Abstract) “Evidence for a Structural Motif in Toxins and Interleukin-2 That May be Responsible for Binding to Endothelial Cells and Initiating Vascular Leak Symdrome” Journal: Proc. Natl. Acad. Sci. USA, vol. 96, Issue: 7, pp. 3957-3962 (1999).
M.G. Battelli et al, (Abstract) “Toxicity and Cytotoxicity of Nigrin B, A Two-Chain Ribosome-Inactivating Protein from Sambucus Nigra: Comparison With Ricin” Journal: Arch Toxicol, vol. 71, Issue: 6, pp. 360-364, (1997).
C.E. Bennett et al, (Abstract) “Studies on Toxicity and Binding Kenetics of Abrin in Normal and Epstein Barr Virus-Transformed Lymphocyte Culture-I: Experimental Results-2”, Journal: Exp. Cell Biol., vol. 49, Issue: 6, pp. 319-326 (1981).
B. Bernard et al, (Abstract) “Changes in the Sensitivity of Chick Fibroblasts to Ricinus Lectin (RCA I) Toxicity in Relation to the Stage of Embryo Development” Journal: Biochem. J., vol. 182, Issue: 1, pp. 33-38 (1979).
R.F. Brown et al. (Abstract) “Ultrastructure of Rat Lung Following Inhalation of Ricin Aerosol” Journal: Int. J. Exp. Pathol., vol. 78, Issue: 4, pp. 267-276 (1997).
C. Campbell et al, (Abstract) “A Dominant Mutation to Ricin Resistance in Chinese Hamster Ovary Cells Induces UDP-GLcNAc: Glycopeptide Beta-4-N-Acetylglucosaminyltransferase III Activity” Journal: J. Biol. Chem., vol. 259, Issue: 21, pp. 13370-13378 (1984).
M.M. Campos et al (Abstract) “Effect of Canatoxin on Cell Cultures”, Journal: Cell Biol. Int. Rep. vol. 15, Issue: 7, pp. 581-594 (1991).
M.R. Carvalho et al (Abstract) “Relative Importance of Phytohemagglutinin (Lectin) and Trypsinchymotrypsin Inhibitor on Bean (Phaseolus vulgaris L) Protein Absroption and Utilization by the Rat” Journal J. Nutr. Sci. Vitaminol (Tokyo), vol. 44, Issue: 5, pp. 685-696 (1998).
B. Chazaud et al, (Abstract) “Ricin Toxicity and Intracellular Routing in Tumoral HT-29 Cells. II. Differential Ricin Toxicity from the Apical and Basolateral Surfaces of Differentiated HT-29 Cells” Journal: Exp. Cell Res., vol. 221, Issue: 1, pp. 214-220 (1995).
L. Citores et al, (Abstract) “Differential Sensitivity of HeLa Cells to the Type 2 Ribosome-Inactivating Proteins Ebulin I, Nigrin B and Nigrin F as Compared with Ricin” Journal: Cell Mol. Biol (Noisy-Le-Grand), vol. 42, Issue: 4, pp. 473-476 (1996).
M. Derenzini et al, (Abstract) “Toxic Effects of Ricin: Studies on the Pathogenesis of Liver Lesions” Journal: Virchows Arch. B Cell Pathol., vol. 20, Issue: 1, pp. 15-28 (1976).
P.S. Distefano et al. (Abstract) “Selective Destruction of Nerve Growth Factor Receptor-Bearing Cells in Vitro Using a Hybrid Toxin Composed of Ricin A Chain and a Monoclonal Antibody Against the Nerve Growth Factor Receptor” Journal: J. Cell Biol., vol. 101, Issue: 3, pp. 1107-1114 (1985).
M. Dodeur et al, (Abstract) “Toxic Effect of Ricinus Lectin on Hepatoma Cells in Relation to Enzyme Modification of the Cell Surface”, Journal: Biochim. Biophys. Acta., vol. 628, Issue: 3, pp. 303-313 (1980).
R.J. Fulton et al, (Abstract) “Purification of Ricin A1, A2 and B Chains and Characterization of Their Toxicity”, Journal: J. Biol. Chem., vol. 261, Issue: 12, pp. 5314-5319 (1986).
K. Ghoreschi et al, (Abstract) “Functional Role of CD95 Ligand in Concanavalin A-Induced Intestinal Intraepithelial Lymphocyte Cytotoxicity”, Journal: Immunology

Affiliated with

Also associated with

Rating

Method of culturing cells in suspension using lectins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of culturing cells in suspension using lectins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of culturing cells in suspension using lectins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2462027